Superior reduction of HbA1c in a double-blind, randomized study of basal insulin peglispro (BIL) vs. insulin glargine (GL) in patients (pts) with T1D: IMAGINE 3 [abstract]
Abstract
Overview
authors
Bergenstal, Richard M., MD
Lunt, H.
Franek, E.
Travert, F.
Mou, J.
Hartman, M. L.
Rosilio, M.
Bastyr, E. J.
publication date
2015
published in
Diabetes
Journal
Research
keywords
Diabetes
Drugs
Randomized Controlled Trials
Additional Document Info
volume
64
issue
Suppl 1
